Tornaletti Silvia, Maeda Lauren S, Hanawalt Philip C
Department of Biological Sciences, Stanford University, Stanford, California 94305-5020, USA.
Chem Res Toxicol. 2006 Sep;19(9):1215-20. doi: 10.1021/tx060103g.
A dedicated excision repair pathway, termed transcription-coupled repair (TCR), targets the removal of DNA lesions from transcribed strands of expressed genes. Transcription arrest at the site of the lesion has been proposed as the first step for initiation of TCR. In support of this model, a strong correlation between arrest of transcription by a lesion in vitro and TCR of that lesion in vivo has been found in most cases analyzed. TCR has been reported for oxidative DNA damage; however, very little is known about how frequently occurring and spontaneous DNA damage, such as depurination and base deamination, affects progression of the transcription complex. We have previously determined that the oxidative lesion, thymine glycol, is a significant block to transcription by T7 RNA polymerase (T7 RNAP) but has no detectable effect on transcription by RNA polymerase II (RNAP II) in a reconstituted system with all of the required factors. Another oxidative lesion, 8-oxoguanine, only slightly blocked T7 RNAP and caused RNAP II to briefly pause at the lesion before bypassing it. Because an abasic site is an intermediate in the repair of oxidative damage, it was of interest to learn whether it arrested transcription. Using in vitro transcription assays and substrates containing a specifically positioned lesion, we found that an abasic site in the transcribed strand is a 60% block to transcription by T7 RNAP but nearly a complete block to transcription by mammalian RNAP II. An abasic site in the nontranscribed strand did not block either polymerase. Our results clearly indicate that an abasic site is a much stronger block to transcription than either a thymine glycol or an 8-oxoguanine. Because the predominant model for TCR postulates that only lesions that block RNAP will be subject to TCR, our findings suggest that the abasic site may be sufficient to initiate TCR in vivo.
一种名为转录偶联修复(TCR)的专用切除修复途径,旨在从已表达基因的转录链上去除DNA损伤。损伤部位的转录停滞被认为是启动TCR的第一步。支持该模型的是,在大多数分析的案例中,体外损伤导致的转录停滞与体内该损伤的TCR之间存在很强的相关性。已有报道称TCR可修复氧化性DNA损伤;然而,对于频繁发生的自发性DNA损伤,如脱嘌呤和碱基脱氨基,如何影响转录复合物的进展却知之甚少。我们之前已经确定,氧化性损伤产物胸腺嘧啶乙二醇是T7 RNA聚合酶(T7 RNAP)转录的一个重要阻碍,但在含有所有必需因子的重组系统中,对RNA聚合酶II(RNAP II)的转录没有可检测到的影响。另一种氧化性损伤产物8-氧鸟嘌呤仅轻微阻碍T7 RNAP,并使RNAP II在损伤部位短暂停顿后绕过它。由于无碱基位点是氧化性损伤修复的中间产物,因此了解它是否会使转录停滞很有意义。通过体外转录试验和含有特定位置损伤的底物,我们发现转录链上的无碱基位点对T7 RNAP的转录有60%的阻碍作用,但对哺乳动物RNAP II的转录几乎完全阻碍。非转录链上的无碱基位点对两种聚合酶都没有阻碍作用。我们的结果清楚地表明,无碱基位点对转录的阻碍作用比胸腺嘧啶乙二醇或8-氧鸟嘌呤都要强得多。因为TCR的主要模型假定只有阻碍RNAP的损伤才会受到TCR的作用,我们的发现表明无碱基位点可能足以在体内启动TCR。